Evidation, co-founded by Stanford University and GE Ventures, has picked up series E funding at a $1bn valuation.
Evidation Health, a US-based health data analysis provider, has picked up $153m in a series E round co-led by healthcare consortium Kaiser Permanente’s Group Trust.
The round was co-led by Omers Growth Equity, a fund managed by pension fund Ontario Municipal Employees Retirement System, and included McKesson Ventures, the corporate venturing arm of medical supplies distributor McKesson, as well as venture capital firm B Capital Group.
Evidation’s technology platform, Achievement, records raw behaviour data such as speech and video from patients’ electronic devices and analyses it to provide insights on health and disease. The round valued it at $1bn, according to Bloomberg.
The company was founded in 2012 through a partnership between Stanford University and GE Ventures, a corporate venturing subsidiary of industrial technology conglomerate General Electric.
It will use the funding to expand the number of virtual health programmes on Achievement.
B Capital Group…
